Below you will find an index of position statements and submissions produced by RANZCR as part of our work to advocate for the clinical radiology and radiation oncology professions. Search by keyword and use the filters to find what you're looking for.
Return to the Advocacy page
RANZCR has made a submission to the Health and Disability Review in response to their interim report. RANZCR’s submission calls for a more integrated system to better support accessible, more patient centred health services,...
The RANZCR submission detailed the availability and delivery of safe and high-quality imaging services to South Australian patients, training a sustainable workforce and safe care and reasonable workloads.
Seven...
December 2019
RANZCR’s Faculty of Radiation Oncology developed a paper on Establishing and Sustaining Regional, Rural and Remote Radiation Therapy Centres in 2016. It provides guidance on expected standards for the...
The Australian Government has established a National Dust Disease Taskforce to develop a national approach for the prevention, early identification, control and management of dust diseases in Australia. The Taskforce requested...
RANZCR has made a submission to the Ministry of Health in response to the Cancer Action Plan. The College's submission is based around the four outcomes listed in the Plan:
This position statement has been developed by the Faculty of Clinical Radiology to provide advice regarding communication of significant unexpected, urgent or critical clinical radiology findings as well as documentation of...
Imaging of Occupational Lung Disease Position Statement
In Australia a significant incidence of silicosis in workers exposed to the dust from high silica content engineered stone has been identified. Imaging has a central...
The nine ethical principles outlined guide the development of professional and practice standards regarding the research and deployment of machine learning systems (ML) and artificial intelligence tools (AI) in medicine. These...
The Faculty of Radiation Oncology appreciates being given the opportunity to provide feedback on the MBS Review Taskforce Report from the Report from the Specialist and Consultant Physician Consultation Clinical Committee and...
Page 6 of 14